Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Affimed $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market
ANE HK$1.1 billion IPO
We advised ANE on its IPO and HKEX listing
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Millicom $2.2 billion acquisition of full control of Tigo Guatemala
We are advising Millicom on the transaction
Mountain & Co. I Acquisition $230 million IPO
We advised the SPAC on its IPO and Nasdaq listing
Rio Tinto $1.25 billion notes offering and cash tender offer
The 2.75% investment-grade notes are due 2051 and the concurrent tender offer is for debt due 2025
Tellurian $50 million senior notes offering
The 8.25% investment-grade notes are due 2028
Advent, Permira, Crosspoint and CPPIB $9.98 billion McAfee acquisition financing
We are advising the joint lead arrangers on the financing
Alliance Data Systems spinoff of Loyalty Ventures
We advised Alliance Data Systems on its spinoff transaction
Government of Belize debt restructuring
Belize completed settlement of its cash tender offer and consent solicitation for its U.S. dollar bonds due 2034